{"transactions":[{"id":1306599,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-08T21:23:52.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":727,"price":0.64,"value":465.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":17287,"source":{"system":"sec-edgar","filing":"0001104659-25-002042","document":"tm252282-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925002042/tm252282-1_4seq1.xml","form_type":"4"}},{"id":1388087,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-10T21:00:12.000Z","date":"2024-10-09","kind":"sale","planned":false,"acquired":false,"shares":476,"price":0.446,"value":212.296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":18014,"source":{"system":"sec-edgar","filing":"0001104659-24-107747","document":"tm2425931-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924107747/tm2425931-1_4seq1.xml","form_type":"4"}},{"id":1459903,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T18:34:36.000Z","date":"2024-07-02","kind":"sale","planned":false,"acquired":false,"shares":621,"price":1.07,"value":664.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.05 - $1.16, inclusive. The Reporting Person undertakes to provide Entero Therapeutics, Inc. (\"Entero\"), any security holder of Entero, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":18490,"source":{"system":"sec-edgar","filing":"0001104659-24-077714","document":"tm2418821-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924077714/tm2418821-2_4seq1.xml","form_type":"4"}},{"id":1549501,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T21:13:29.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":75,"price":4.2294,"value":317.205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":19111,"source":{"system":"sec-edgar","filing":"0001104659-24-043154","document":"tm2411006-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924043154/tm2411006-2_4seq1.xml","form_type":"4"}},{"id":1568584,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T20:10:46.000Z","date":"2024-03-15","kind":"sale","planned":false,"acquired":false,"shares":1120,"price":4.96,"value":5555.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.90 - $5.175, inclusive. The Reporting Person undertakes to provide First Wave BioPharma, Inc. (\"First Wave\"), any security holder of First Wave, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":19186,"source":{"system":"sec-edgar","filing":"0001104659-24-036138","document":"tm249257-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924036138/tm249257-1_4seq1.xml","form_type":"4"}},{"id":1677865,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-17T21:02:51.000Z","date":"2024-01-12","kind":"sale","planned":false,"acquired":false,"shares":98,"price":4.2,"value":411.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":20306,"source":{"system":"sec-edgar","filing":"0001104659-24-004460","document":"tm243514-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924004460/tm243514-2_4seq1.xml","form_type":"4"}},{"id":1692346,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-04T00:54:55.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On January 2, 2024, the Reporting Person was granted 7,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning April 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":20404,"source":{"system":"sec-edgar","filing":"0001104659-24-001025","document":"tm241923-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924001025/tm241923-2_4seq1.xml","form_type":"4"}},{"id":1692345,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-04T00:54:55.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":12614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 29, 2023, the Reporting Person was granted 12,614  restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest upon closing of the Issuer's proposed acquisition of ImmunogenX, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":13404,"source":{"system":"sec-edgar","filing":"0001104659-24-001025","document":"tm241923-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924001025/tm241923-2_4seq1.xml","form_type":"4"}},{"id":1763588,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-06T20:05:18.000Z","date":"2023-10-04","kind":"sale","planned":false,"acquired":false,"shares":1676,"price":0.29,"value":486.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.291 to $0.293. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":15800,"source":{"system":"sec-edgar","filing":"0001104659-23-107483","document":"tm2327991-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923107483/tm2327991-2_4seq1.xml","form_type":"4"}},{"id":1836108,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:28:02.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":1977,"price":1.54,"value":3044.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.49 to $1.61. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":17476,"source":{"system":"sec-edgar","filing":"0001104659-23-078145","document":"tm2320603-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923078145/tm2320603-2_4seq1.xml","form_type":"4"}},{"id":1925058,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T20:17:52.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":1975,"price":2.5,"value":4937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.41 to $2.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"All amounts reflect the 1:7 reverse stock split effective as of January 18, 2023"}],"balance_after":19453,"source":{"system":"sec-edgar","filing":"0001104659-23-042170","document":"tm2311820-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923042170/tm2311820-2_4seq1.xml","form_type":"4"}},{"id":2062604,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-05T14:01:50.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 3, 2023, the Reporting Person was granted 150,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001104659-23-001230","document":"tm231522-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923001230/tm231522-6_4seq1.xml","form_type":"4"}},{"id":2360584,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-03-02T23:02:48.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three equal annual installments commencing on March 1, 2023."}],"balance_after":150000,"derivative":{"exercise_price":1.18,"expiration_date":"2032-03-01","underlying":"Common stock, par value $0.0001 per share","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-22-007549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122007549/form4.xml","form_type":"4"}},{"id":2401167,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T21:31:07.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":108,"price":0.69,"value":74.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":22746,"source":{"system":"sec-edgar","filing":"0001104659-22-020560","document":"tm226424-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922020560/tm226424-1_4seq1.xml","form_type":"4"}},{"id":2413138,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:06:39.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":50000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-22-011498","document":"tm225348d10_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011498/tm225348d10_4.xml","form_type":"4"}},{"id":2441107,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-06T22:10:50.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":114,"price":1.08,"value":123.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022."}],"balance_after":22854,"source":{"system":"sec-edgar","filing":"0001104659-22-001943","document":"tm222161-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922001943/tm222161-2_4seq1.xml","form_type":"4"}},{"id":2480262,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:15:57.000Z","date":"2021-12-07","kind":"tax_withholding","acquired":false,"shares":91,"price":1.3,"value":118.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2021."}],"balance_after":22968,"source":{"system":"sec-edgar","filing":"0001104659-21-147635","document":"tm2134911d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921147635/tm2134911d1_4seq1.xml","form_type":"4"}},{"id":2525826,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-03T20:15:40.000Z","date":"2021-11-02","kind":"tax_withholding","acquired":false,"shares":83,"price":1.98,"value":164.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021."}],"balance_after":23059,"source":{"system":"sec-edgar","filing":"0001104659-21-133650","document":"tm2131814-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921133650/tm2131814-1_4seq1.xml","form_type":"4"}},{"id":2548250,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-05T22:40:38.000Z","date":"2021-10-04","kind":"tax_withholding","acquired":false,"shares":83,"price":2.01,"value":166.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021."}],"balance_after":23142,"source":{"system":"sec-edgar","filing":"0001104659-21-123267","document":"tm2129310d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921123267/tm2129310d3_4seq1.xml","form_type":"4"}},{"id":2578651,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:16:06.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":84,"price":1.81,"value":152.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.81, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":23225,"source":{"system":"sec-edgar","filing":"0001104659-21-112940","document":"tm2126978-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921112940/tm2126978-2_4seq1.xml","form_type":"4"}},{"id":2614400,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-04T21:45:42.000Z","date":"2021-08-03","kind":"tax_withholding","acquired":false,"shares":87,"price":2.4,"value":208.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021."}],"balance_after":23309,"source":{"system":"sec-edgar","filing":"0001104659-21-100196","document":"tm2124160d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921100196/tm2124160d1_4seq1.xml","form_type":"4"}},{"id":2640684,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-06T20:32:11.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":180,"price":3.7,"value":666.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/01/2021."}],"balance_after":23396,"source":{"system":"sec-edgar","filing":"0001104659-21-089447","document":"tm2121558d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921089447/tm2121558d4_4.xml","form_type":"4"}},{"id":2678921,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-07T21:02:16.000Z","date":"2021-06-04","kind":"tax_withholding","acquired":false,"shares":180,"price":4.19,"value":754.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 06/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.39, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":23576,"source":{"system":"sec-edgar","filing":"0001104659-21-077765","document":"tm2119042d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921077765/tm2119042d3_4seq1.xml","form_type":"4"}},{"id":2726653,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-06T01:57:37.000Z","date":"2021-05-04","kind":"tax_withholding","acquired":false,"shares":177,"price":4.13,"value":731.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 05/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.48, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":23756,"source":{"system":"sec-edgar","filing":"0001104659-21-061949","document":"tm2115347d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921061949/tm2115347d3_4.xml","form_type":"4"}},{"id":2751951,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-09T20:16:16.000Z","date":"2021-04-08","kind":"tax_withholding","acquired":false,"shares":180,"price":4.94,"value":889.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 04/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.71 to $4.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":23933,"source":{"system":"sec-edgar","filing":"0001104659-21-048715","document":"tm2112624-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921048715/tm2112624-3_4seq1.xml","form_type":"4"}},{"id":2805444,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-05T21:31:30.000Z","date":"2021-03-03","kind":"tax_withholding","acquired":false,"shares":218,"price":5.46,"value":1190.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 03/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.41 to $5.46, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":24113,"source":{"system":"sec-edgar","filing":"0001104659-21-032766","document":"tm218853-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921032766/tm218853-3_4.xml","form_type":"4"}},{"id":2880997,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T02:53:13.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":30000,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-21-011850","document":"tm215262-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921011850/tm215262-8_4seq1.xml","form_type":"4"}},{"id":2880996,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-04T02:53:13.000Z","date":"2021-02-02","kind":"tax_withholding","acquired":false,"shares":1282,"price":6.34,"value":8127.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.34 to $6.35, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":24331,"source":{"system":"sec-edgar","filing":"0001104659-21-011850","document":"tm215262-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921011850/tm215262-8_4seq1.xml","form_type":"4"}},{"id":2919283,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:16:43.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":115,"price":4.85,"value":557.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.84 to $4.85, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":25613,"source":{"system":"sec-edgar","filing":"0001104659-21-000934","document":"tm211689-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921000934/tm211689-3_4seq1.xml","form_type":"4"}},{"id":2953121,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-09T01:16:56.000Z","date":"2020-12-07","kind":"tax_withholding","acquired":false,"shares":91,"price":3.76,"value":342.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2020."}],"balance_after":25728,"source":{"system":"sec-edgar","filing":"0001104659-20-133323","document":"tm2038041-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920133323/tm2038041-1_4.xml","form_type":"4"}},{"id":2994330,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-03T21:15:43.000Z","date":"2020-11-02","kind":"tax_withholding","acquired":false,"shares":97,"price":3.51,"value":340.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2020."}],"balance_after":25819,"source":{"system":"sec-edgar","filing":"0001104659-20-120953","document":"tm2034888d2_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920120953/tm2034888d2_form4.xml","form_type":"4"}},{"id":3012625,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T21:57:00.000Z","date":"2020-10-02","kind":"tax_withholding","acquired":false,"shares":98,"price":3.88,"value":380.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 10/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":25916,"source":{"system":"sec-edgar","filing":"0001104659-20-112301","document":"tm2032523-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920112301/tm2032523-2_4.xml","form_type":"4"}},{"id":3038721,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-03T21:30:33.000Z","date":"2020-09-02","kind":"tax_withholding","acquired":false,"shares":97,"price":3.94,"value":382.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2020."}],"balance_after":26014,"source":{"system":"sec-edgar","filing":"0001104659-20-102296","document":"tm2030216d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920102296/tm2030216d1_form4.xml","form_type":"4"}},{"id":3066986,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-05T21:12:24.000Z","date":"2020-08-04","kind":"tax_withholding","acquired":false,"shares":95,"price":4.11,"value":390.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 08/01/2020."}],"balance_after":26111,"source":{"system":"sec-edgar","filing":"0001104659-20-090920","document":"tm2026743-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920090920/tm2026743-4_4.xml","form_type":"4"}},{"id":3088336,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T20:15:41.000Z","date":"2020-07-02","kind":"tax_withholding","acquired":false,"shares":97,"price":4.82,"value":467.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/01/2020."}],"balance_after":26206,"source":{"system":"sec-edgar","filing":"0001104659-20-081223","document":"tm2024119-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920081223/tm2024119-2_4.xml","form_type":"4"}},{"id":3121742,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-04T20:17:43.000Z","date":"2020-06-03","kind":"tax_withholding","acquired":false,"shares":94,"price":5.11,"value":480.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 06/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.11 to $5.1781, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":26303,"source":{"system":"sec-edgar","filing":"0001104659-20-069824","document":"tm2021837-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920069824/tm2021837-3_4.xml","form_type":"4"}},{"id":3159204,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-06T20:31:55.000Z","date":"2020-05-05","kind":"tax_withholding","acquired":false,"shares":93,"price":5.1,"value":474.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 05/01/2020."}],"balance_after":26397,"source":{"system":"sec-edgar","filing":"0001104659-20-057474","document":"tm2018856d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920057474/tm2018856d4_4.xml","form_type":"4"}},{"id":3182606,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-03T21:54:59.000Z","date":"2020-04-02","kind":"tax_withholding","acquired":false,"shares":122,"price":4.97,"value":606.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 04/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $5.09, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":26490,"source":{"system":"sec-edgar","filing":"0001104659-20-043261","document":"tm2014998d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920043261/tm2014998d1_form4.xml","form_type":"4"}},{"id":3217260,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-10T23:12:38.000Z","date":"2020-03-09","kind":"tax_withholding","acquired":false,"shares":130,"price":5.01,"value":651.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 03/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.07, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":26612,"source":{"system":"sec-edgar","filing":"0001104659-20-031496","document":"tm2012338d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920031496/tm2012338d1_4.xml","form_type":"4"}},{"id":3262317,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:32:42.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2021, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":10000,"derivative":{"exercise_price":6.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-022848","document":"tm209305-8_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920022848/tm209305-8_4.xml","form_type":"4"}},{"id":3262316,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-19T21:32:42.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on February 1, 2021, and the remaining balance will vest monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":26742,"source":{"system":"sec-edgar","filing":"0001104659-20-022848","document":"tm209305-8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920022848/tm209305-8_4.xml","form_type":"4"}},{"id":3288237,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-05T22:00:54.000Z","date":"2020-02-04","kind":"tax_withholding","acquired":false,"shares":109,"price":6,"value":654.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2020."}],"balance_after":16742,"source":{"system":"sec-edgar","filing":"0001104659-20-011314","document":"tm206871d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920011314/tm206871d1_4.xml","form_type":"4"}},{"id":3317615,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-06T22:47:48.000Z","date":"2020-01-03","kind":"tax_withholding","acquired":false,"shares":119,"price":9.52,"value":1132.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2020"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.3537 to $9.52, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":16851,"source":{"system":"sec-edgar","filing":"0001104659-20-001637","document":"tm201302-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920001637/tm201302-2_4.xml","form_type":"4"}},{"id":3333687,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-20T22:28:30.000Z","date":"2019-12-18","kind":"tax_withholding","acquired":false,"shares":101,"price":7.46,"value":753.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.46 to $7.53, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":16970,"source":{"system":"sec-edgar","filing":"0001104659-19-075136","document":"tm1926709d4_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465919075136/tm1926709d4_form4.xml","form_type":"4"}},{"id":3377428,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-07T21:15:44.000Z","date":"2019-11-05","kind":"tax_withholding","acquired":false,"shares":108,"price":3.85,"value":415.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $3.85, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":17071,"source":{"system":"sec-edgar","filing":"0001104659-19-061124","document":"tm1922166-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465919061124/tm1922166-4_4.xml","form_type":"4"}},{"id":3394257,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-11T20:06:14.000Z","date":"2019-10-09","kind":"tax_withholding","acquired":false,"shares":185,"price":3.1,"value":573.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2019 and 10/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.37, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split."}],"balance_after":17179,"source":{"system":"sec-edgar","filing":"0001144204-19-048123","document":"tv530956_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419048123/tv530956_4.xml","form_type":"4"}},{"id":3444348,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-07T23:21:38.000Z","date":"2019-08-06","kind":"tax_withholding","acquired":false,"shares":1649,"price":0.21,"value":346.29,"ownership":{"direct":true},"balance_after":260464,"source":{"system":"sec-edgar","filing":"0001144204-19-038334","document":"tv527077_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419038334/tv527077_4.xml","form_type":"4"}},{"id":3461840,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-16T00:39:01.000Z","date":"2019-07-15","kind":"sale","acquired":false,"shares":6584,"price":0.233,"value":1534.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.227 to $0.2403, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":262113,"source":{"system":"sec-edgar","filing":"0001144204-19-034766","document":"tv525232_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419034766/tv525232_4.xml","form_type":"4"}},{"id":3461839,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-16T00:39:01.000Z","date":"2019-07-12","kind":"sale","acquired":false,"shares":6583,"price":0.2356,"value":1550.9548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2257 to $0.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":268697,"source":{"system":"sec-edgar","filing":"0001144204-19-034766","document":"tv525232_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419034766/tv525232_4.xml","form_type":"4"}},{"id":3461838,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-16T00:39:01.000Z","date":"2019-07-11","kind":"sale","acquired":false,"shares":6583,"price":0.2406,"value":1583.8698,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.24 to $0.245, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":275280,"source":{"system":"sec-edgar","filing":"0001144204-19-034766","document":"tv525232_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419034766/tv525232_4.xml","form_type":"4"}},{"id":3673728,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T21:34:28.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2020, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":50000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-005039","document":"tv512439_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419005039/tv512439_form4.xml","form_type":"4"}},{"id":3868484,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-12T20:51:15.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":281863,"source":{"system":"sec-edgar","filing":"0001144204-18-038182","document":"tv498474_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418038182/tv498474_4.xml","form_type":"4"}},{"id":3960798,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (right to buy)","published_at":"2018-04-18T21:22:51.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018. Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32."}],"balance_after":62500,"derivative":{"exercise_price":0.32,"exercise_date":"2018-04-17","expiration_date":"2023-04-17","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001144204-18-021205","document":"tv491362_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418021205/tv491362_4.xml","form_type":"4"}},{"id":3960797,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-18T21:22:51.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018. Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32."}],"balance_after":106863,"source":{"system":"sec-edgar","filing":"0001144204-18-021205","document":"tv491362_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418021205/tv491362_4.xml","form_type":"4"}},{"id":4023320,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T21:21:13.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 28, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":25000,"derivative":{"exercise_price":0.57,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-18-012247","document":"tv487523_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418012247/tv487523_4.xml","form_type":"4"}},{"id":4110690,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:10:19.000Z","date":"2017-12-29","kind":"other","acquired":true,"shares":11863,"price":1.01,"value":11981.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan on December 29, 2017 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":44363,"source":{"system":"sec-edgar","filing":"0001144204-18-000500","document":"tv482539_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418000500/tv482539_4.xml","form_type":"4"}},{"id":4230368,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2017-08-17T20:05:41.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":true},"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001144204-17-043873","document":"v473586_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417043873/v473586_4.xml","form_type":"4"}},{"id":4274302,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T20:26:51.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on June 21, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":40000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001144204-17-033640","document":"v469459_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417033640/v469459_4.xml","form_type":"4"}},{"id":4281957,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Warrants (right to buy)","published_at":"2017-06-14T20:51:28.000Z","date":"2017-06-14","kind":"purchase","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $1.50 per share of common stock and warrant in connection with the Issuer's public offering that closed on June 14, 2017. Each warrant will be exercisable during the period commencing on June 14, 2017 and ending on June 14, 2022 at an exercise price of $1.50."}],"balance_after":20000,"derivative":{"exercise_price":1.5,"exercise_date":"2017-06-14","expiration_date":"2022-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-032554","document":"v469022_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417032554/v469022_form4.xml","form_type":"4"}},{"id":4281956,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2017-06-14T20:51:28.000Z","date":"2017-06-14","kind":"purchase","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $1.50 per share of common stock and warrant in connection with the Issuer's public offering that closed on June 14, 2017. Each warrant will be exercisable during the period commencing on June 14, 2017 and ending on June 14, 2022 at an exercise price of $1.50."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001144204-17-032554","document":"v469022_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417032554/v469022_form4.xml","form_type":"4"}},{"id":4461214,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2017-02-08T21:27:57.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on February 6, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-17-006751","document":"v458795_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417006751/v458795_4.xml","form_type":"4"}}]}